Piedmont Cancer Institute, PC is a clinical research site located in Atlanta, Georgia, United States 30318.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Piedmont Cancer Institute, PC has participated in 14 clinical trials with 2 currently active.
Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer.
Sponsors: Daiichi Sankyo, Pfizer, Medical College of Wisconsin.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Piedmont Cancer Institute, PC has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Piedmont Cancer Institute, PC has 14 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer.
Yes — Piedmont Cancer Institute, PC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.